General Surgery Coding Alert - 2007 Issue 35
PHYSICIAN NOTES: Senate Stymied On Medicare Payment Fixes
Subscribe or sign in to view the full article.
Article Overview
This article covers Medicare policy developments affecting physicians, cancer care, and beneficiary coverage, along with related health policy and enforcement news. It discusses congressional efforts to address physician payment cuts, Medicare coverage issues for cancer clinical trials and chemotherapy-related therapies, the 2008 Medicare Part B premium, a chronic disease cost study, and a fraud case involving durable medical equipment billing. The piece is relevant to physicians, oncology practices, medical billing professionals, and health policy readers tracking Medicare changes and enforcement activity.
Why This Topic Matters
It helps readers monitor federal Medicare policy changes that can affect reimbursement, coverage access, and compliance risk. The article also highlights broader health economics and fraud enforcement issues that may affect practice operations and payer oversight.
Article Sections
-
Medicare payment fix efforts
Coverage of congressional efforts to address physician payment cuts and possible funding sources under discussion. The section focuses on the status of Medicare legislation and related budget pressures.
-
Cancer clinical trial coverage
Discussion of Medicare coverage for cancer patients participating in clinical trials and the agencies involved in that coverage policy. It also touches on broader oncology advocacy concerns.
-
Medicare Part B premium update
A brief update on the upcoming Medicare Part B monthly premium for 2008 and how it compares with the prior year.
-
Chronic disease cost study
Summary of a new report estimating the economic burden of chronic disease in terms of lost productivity and treatment costs.
-
Fraud and enforcement case
A report on a federal prosecution involving alleged kickbacks and improper durable medical equipment certifications. The section describes the enforcement outcome and the agencies and providers involved.
What You Will Learn
- How Congress was trying to address Medicare physician payment reductions
- What the article says about Medicare coverage for cancer clinical trials
- Which agencies were involved in the clinical trial coverage policy discussion
- How the 2008 Medicare Part B premium changed
- What the chronic disease cost study reported
- What the fraud case involved in broad terms
Who Should Read This
- Physicians
- Medical practice administrators
- Medical coders and billers
- Oncology practices
- Health policy professionals
- Compliance officers
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com